Hu, Yunhui <br/><br/>
Sabutoclax, pan-active BCL-2 protein family antagonist, overcomes drug resistance and eliminates cancer stem cells in breast cancer.  [electronic resource] 

 -  Cancer letters  06 2018 
 - 47-59 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1872-7980 
<br/><br/><label>Standard No.: </label>10.1016/j.canlet.2018.02.036  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Breast Neoplasms--drug therapy<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cell Survival--drug effects<br/>Doxorubicin--administration & dosage<br/>Drug Resistance, Neoplasm--drug effects<br/>Drug Synergism<br/>Female<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Gossypol--administration & dosage<br/>Humans<br/>Interleukin-6--metabolism<br/>MCF-7 Cells<br/>Mice<br/>Neoplastic Stem Cells--drug effects<br/>STAT3 Transcription Factor--metabolism<br/>Signal Transduction--drug effects<br/>Xenograft Model Antitumor Assays